‘Don’t ignore the threat’: WHO warns of Ebola spread across Africa
The outbreak has resulted in 160 suspected deaths out of 670 cases
The WHO regional director for Africa has reportedly issued a warning that it would be a significant mistake to underestimate the threat posed by the Ebola outbreak on Friday.
One needs to be cautioned as just one case could spread the virus beyond the Democratic Republic of Congo and Uganda.
According to DRC health ministry data published on Thursday, the outbreak has resulted in 160 suspected deaths out of 670 suspected cases, with 61 cases now confirmed.
“It would be a big mistake to underestimate it, especially with a virus with this strain, Bundibugyo, (for) which we don't have the vaccine,” Mohamed Yakub Janabi said in an interview at WHO headquarters in Geneva.
“You just need one contact case to put all of us at risk, so my wish and prayer is that we should give (Ebola) the attention it deserves,” he said.
Concerning the situation, Janabi declined to comment on the expected scale of the current outbreak, and experts are efficiently in the process of scrutinizing the entire situation.
The “hyperdynamic movement of the people" made it challenging to evaluate the situation, even as the efforts were made to scale up testing, prevention measures and community engagement.
Notably, epidemiologists have yet to recognize the case, which is pivotal for scrutinizing and isolating the initial web of contacts.
-
UConn Health faces $54.3 million cost increase for 2027: Here’s how it plans to cut costs
-
Deadly Ebola outbreak in Congo continues to spread across health zones
-
Colorectal Cancer Alliance weighs in on New ACS screening guidelines
-
Richard Scolyer Dies at 59: Pioneer cancer researcher received world-first brain tumor treatment
-
New triple-action diabetes jab delivers impressive blood sugar and weight-loss results
-
WHO unveils $518 million strategy to curb Africa Ebola outbreak
-
US measles cases surge past 2,000 as outbreak continues to spread
-
AI breakthrough: ‘world’s first’ vaccine designed by AI enters human trials
